Randox Licenses sPLA2 CVD Risk Test from Aterovax

Product News   May 02, 2013

 
Randox Licenses sPLA2 CVD Risk Test from Aterovax
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Product News

The exclusive licence enables the development and commercialisation of 5hmC technologies for epigenetic biomarker discovery.

READ MORE

Take Part in the Artel Pipetting Challenge Throughout Lab Week!

Product News

The Pipetting Challenge is a fun and unique competition with teams competing from their respective laboratories, using the Artel PCS Pipette Calibration System to achieve the lowest coefficient of variation (CV).

READ MORE

Bio-Rad's ddPCR Highlighted at AACR 2017

Product News

New research has been presented demonstrating the pivotal role of Bio-Rad’s ddPCR™ technology in detecting cell-free DNA and RNA biomarkers in cancer liquid biopsies

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE